From Stem Cells to Insulin Producing ß-cells
In this round table video clip, Dr. Camillo Ricordi and Dr. Melena Bellin discuss the current strategies being studied for restoring glycemic control in Type 1 Diabetes with stem cells.
Dr. Jill interviews Dr. Chadwick Prodromos on Stem Cell Treatment and Regenerative Medicine
In episode #136, Dr. Jill Carnahan speaks with Dr. Chadwick Prodromos about the exciting developments in stem cell treatment and how it is revolutionizing our approach to disease and aging. Stem cells have the unique ability to develop into any type of cell in the body, making them a promising tool for repairing and regenerating […]
Global Stem Cells Market to Generate Revenue of $25.68 Billion By 2028 | More than 80% of Revenue Comes from Adult Stem Cells
Westford,USA, Nov. 02, 2022 (GLOBE NEWSWIRE) — The demand for stem cells market is growing rapidly as the potential for their use in medical treatments expands. In particular, there is great interest in using stem cells to treat a range of degenerative diseases and injuries, as well as to improve the success of organ transplants. Recent advances […]
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world’s premier diabetic foot conference (DFCon) in Los Angeles
LOS ANGELES, Sept. 26, 2022 /PRNewswire/ — CRC is delighted to announce attendance at DFCon, the global specialist multidisciplinary congress focused on the diabetic foot held in late September 2022 in Los Angeles, USA. The meeting is a gathering of a wide range of both generalists and specialists who diagnose and manage diabetic feet, to […]
Seraxis Announces Appointment of Chief Medical Officer, Dr. Paul Strumph
GERMANTOWN, Md., Aug. 30, 2022 (GLOBE NEWSWIRE) — The regenerative medicine company Seraxis Inc. today announced the appointment of Paul Strumph, M.D. as Chief Medical Officer. Dr. Strumph is an endocrinology and diabetes care and research specialist with a successful career of bringing anti-diabetes treatments to market. He will drive the company’s clinical and medical […]
Can stem cells shape the future of medicine? | Esther Wolfs
At this very moment, research is being done on Charcot-Marie-Tooth disease type 1A. Esther is a leading researcher in this field and will tell you more about how cancer and other global diseases can be cured using this new technique. Esther uses stem cells in anticancer therapy and as a model to study Charcot-Marie-Tooth disease […]
Biorep Technologies, Inc. Joins the Tetra Partner Network to Accelerate Research into Stem-Cell Derived Insulin to Cure Diabetes
BOSTON, May 31, 2022 /PRNewswire/ — TetraScience, the R&D Data Cloud company, announced today that Biorep Technologies, Inc., the leading provider of scientific instruments that help pharmaceutical companies and leading universities research cures for Type 1 and Type 2 diabetes, has joined the Tetra Partner Network. The partnership builds on a joint deployment of Biorep’s […]